Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): A gold standard to achieve for all surgical platelet concentrates technologies

Growth Factors

Volumn 27, Issue 1, 2009, Pages 63-69

  Dohan Ehrenfest, David M ^a,b,c   de Peppo, Giuseppe M ^a   Doglioli, Pierre ^d   Sammartino, Gilberto ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d Cell Culture Laboratory   (France)

Author keywords

Coagulation; Drug delivery; Fibrin; Growth factors; Platelet concentrate; Platelet rich fibrin; Platelet rich plasma

Indexed keywords

BIOMATERIAL; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AB; PLATELET RICH FIBRIN; THROMBOCYTE CONCENTRATE; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SURGICAL TECHNOLOGY;

BLOOD COAGULATION; BLOOD PLATELETS; CELL SEPARATION; FEMALE; FIBRIN; GENERAL SURGERY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; MALE; MIDDLE AGED; PLATELET-DERIVED GROWTH FACTOR; PLATELET-RICH PLASMA; RECOMBINANT PROTEINS; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 58149105371     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190802636713     Document Type: Article

References (38)

1. Anitua, E. (1999) Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants, 14:4, pp. 529-535.
2. Anitua, E., Sanchez, M., Orive, G. and Andia, I. (2007) The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials, 28:31, pp. 4551-4560.
3. Anitua, E., Aguirre, JJ, Algorta, J., Ayerdi, E., Cabezas, AI, Orive, G. and Andia, I. (2008) Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater, 84:2, pp. 415-421.
4. Appel, TR, Potzsch, B., Muller, J., von Lindern, JJ, Berge, SJ and Reich, RH (2002) Comparison of three different preparations of platelet concentrates for growth factor enrichment. Clin Oral Implants Res, 13:5, pp. 522-528.
5. Bonnefoy, A., Daenens, K., Feys, HB, De Vos, R., Vandervoort, P., Vermylen, J., Lawler, J. and Hoylaerts, MF (2006) Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood, 107:3, pp. 955-964.
6. Braccini, F. and Dohan, DM (2007) The relevance of Choukroun's platelet rich fibrin (PRF) during facial aesthetic lipostructure (Coleman's technique): Preliminary results. Rev Laryngol Otol Rhinol (Bord), 128:4, pp. 255-260.
7. Cenni, E., Ciapetti, G., Pagani, S., Perut, F., Giunti, A. and Baldini, N. (2005) Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts. J Periodontol, 76:3, pp. 323-328.
8. Choukroun, J., Adda, F., Schoeffler, C. and Vervelle, A. (2001) Une opportunite en paro-implantologie: Le PRF. Implantodontie, 42, pp. 55-62.
9. Choukroun, J., Diss, A., Simonpieri, A., Girard, MO, Schoeffler, C., Dohan, SL, Dohan, AJ, Mouhyi, J. and Dohan, DM (2006) Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part V: Histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101:3, pp. 299-303.
10. Choukroun, J., Diss, A., Simonpieri, A., Girard, MO, Schoeffler, C., Dohan, SL, Dohan, AJ, Mouhyi, J. and Dohan, DM (2006) Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101:3, pp. e56-e60.
11. Choukroun, JI, Braccini, F., Diss, A., Giordano, G., Doglioli, P. and Dohan, DM (2007) Influence of platelet rich fibrin (PRF) on proliferation of human preadipocytes and tympanic keratinocytes: A new opportunity in facial lipostructure (Coleman's technique) and tympanoplasty?. Rev Laryngol Otol Rhinol (Bord), 128:1, pp. 27-32.
12. Clark, RA (2001) Fibrin and wound healing. Ann N Y Acad Sci, 936, pp. 355-367.
13. Diss, A., Dohan, DM, Mouhyi, J. and Mahler, P. (2008) Osteotome sinus floor elevation using Choukroun's platelet-rich fibrin as grafting material: A 1-year prospective pilot study with microthreaded implants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 105:5, pp. 572-579.
14. Dohan, DM, Choukroun, J., Diss, A., Dohan, SL, Dohan, AJ, Mouhyi, J. and Gogly, B. (2006) Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III: Leucocyte activation: A new feature for platelet concentrates?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101:3, pp. e51-e55.
15. Dohan, DM, Choukroun, J., Diss, A., Dohan, SL, Dohan, AJ, Mouhyi, J. and Gogly, B. (2006) Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101:3, pp. e45-e50.
16. Dohan, DM, Choukroun, J., Diss, A., Dohan, SL, Dohan, AJ, Mouhyi, J. and Gogly, B. (2006) Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101:3, pp. e37-e44.
17. Dohan, DM and Choukroun, J. (2007) PRP, cPRP, PRF, PRG, PRGF, FC. How to find your way in the jungle of platelet concentrates?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103:3, pp. 305-306.
18. Dohan, DM, Del Corso, M and Charrier, J-B (2007) Cytotoxicity analyses of Choukroun's PRF (platelet rich fibrin) on a wide range of human cells: The answer to a commercial controversy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103:5, pp. 587-593.
19. El-Sharkawy, H., Kantarci, A., Deady, J., Hasturk, H., Liu, H., Alshahat, M. and Van Dyke, TE (2007) Platelet-rich plasma: Growth factors and pro- and anti-inflammatory properties. J Periodontol, 78:4, pp. 661-669.
20. Everts, PA, van Zundert, A., Schonberger, JP, Devilee, RJ and Knape, JT (2008) What do we use: Platelet-rich plasma or platelet-leukocyte gel?. J Biomed Mater Res A, 85:4, pp. 1135-1136.
21. Graziani, F., Ivanovski, S., Cei, S., Ducci, F., Tonetti, M. and Gabriele, M. (2006) The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res, 17:2, pp. 212-219.
22. Italiano Jr, JE, Richardson, JL, Patel-Hett, S., Battinelli, E., Zaslavsky, A., Short, S., Ryeom, S., Folkman, J. and Klement, GL (2008) Angiogenesis is regulated by a novel mechanism: Pro- and anti-angiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood, 111:3, pp. 1227-1233.
23. Jurk, K., Clemetson, KJ, de Groot, PG, Brodde, MF, Steiner, M., Savion, N., Varon, D., Sixma, JJ, Van Aken, H. and Kehrel, BE (2003) Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): An alternative/backup mechanism to von Willebrand factor. Faseb J, 17:11, pp. 1490-1492.
24. Leitner, GC, Gruber, R., Neumuller, J., Wagner, A., Kloimstein, P., Hocker, P., Kormoczi, GF and Buchta, C. (2006) Platelet content and growth factor release in platelet-rich plasma: A comparison of four different systems. Vox Sang, 91:2, pp. 135-139.
25. Martin, P. and Leibovich, SJ (2005) Inflammatory cells during wound repair: The good, the bad and the ugly. Trends Cell Biol, 15:11, pp. 599-607.
26. Marx, RE, Carlson, ER, Eichstaedt, RM, Schimmele, SR, Strauss, JE and Georgeff, KR (1998) Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 85:6, pp. 638-646.
27. Moojen, DJ, Everts, PA, Schure, RM, Overdevest, EP, van Zundert, A., Knape, JT, Castelein, RM, Creemers, LB and Dhert, WJ (2008) Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res, 26:3, pp. 404-410.
28. Nielsen, HJ, Werther, K., Mynster, T., Svendsen, MN, Rosendahl, S., Elley, T. and Skov, F. (2001) Bacteria-induced release of white cell-and platelet-derived vascular endothelial growth factor in vitro. Vox Sang, 80:3, pp. 170-178.
29. Saadoun, AP and Touati, B. (2007) Soft tissue recession around implants: Is it still unavoidable? - Part II. Pract Proced Aesthet Dent, 19:2, pp. 81-87.
30. Sanchez, M., Anitua, E., Azofra, J., Andia, I., Padilla, S. and Mujika, I. (2007) Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med, 35:2, pp. 245-251.
31. Sunitha Raja, V and Munirathnam Naidu, E (2008) Platelet-rich fibrin: Evolution of a second-generation platelet concentrate. Indian J Dent Res, 19:1, pp. 42-46.
32. Thor, A., Franke-Stenport, V., Johansson, CB and Rasmusson, L. (2007) Early bone formation in human bone grafts treated with platelet-rich plasma: Preliminary histomorphometric results. Int J Oral Maxillofac Surg, 36:12, pp. 1164-1171.
33. van Hinsbergh, VW, Collen, A. and Koolwijk, P. (2001) Role of fibrin matrix in angiogenesis. Ann N Y Acad Sci, 936, pp. 426-437.
34. Weibrich, G., Kleis, WK and Hafner, G. (2002) Growth factor levels in the platelet-rich plasma produced by 2 different methods: Curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants, 17:2, pp. 184-190.
35. Weibrich, G., Kleis, WK, Hafner, G. and Hitzler, WE (2002) Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg, 30:2, pp. 97-102.
36. Weibrich, G., Kleis, WK, Buch, R., Hitzler, WE and Hafner, G. (2003) The Harvest Smart PRePTM system versus the Friadent-Schutze platelet-rich plasma kit. Clin Oral Implants Res, 14:2, pp. 233-239.
37. Weibrich, G., Kleis, WK, Hitzler, WE and Hafner, G. (2005) Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: A technical report. Int J Oral Maxillofac Implants, 20:1, pp. 118-123.
38. Werther, K., Christensen, IJ and Nielsen, HJ (2002) Determination of vascular endothelial growth factor (VEGF) in circulating blood: Significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest, 62:5, pp. 343-350.